Actavis to face trimmed US antitrust claims in states' generic drug case
( July 8, 2026, 19:58 GMT | Official Statement) -- MLex Summary: Actavis won summary judgment against state plaintiffs’ US claims accusing it of unlawfully conspiring with Sandoz on the prices of Ammonium Lactate cream and lotion and Desonide lotion in 2011, as well as Fluocinonide solution. District Judge Michael P. Shea denied judgment on all other drugs, including claims related to Desonide lotion in 2013 and a market-allocation agreement with Taro on Fluocinonide solution.See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.